Severance Professor Kim Kyung-sik Appointed President of the Korean Association for Liver Cancer
Jul 03, 2024
Professor Kim Kyung-sik of Yonsei University Severance Hospital was inaugurated as the 26th president of the Korean Liver Cancer Society at the regular general meeting of the Korean Liver Cancer Society in 2024. The term is one year from July 2024 to June 2025.
Chairman Kim Kyung-sik majored in hepatopancreatic surgery and has conducted many clinical experiences and studies in the fields of liver cancer and biliary pancreatic cancer surgery.
Chairman Kim said "The Korean Liver Cancer Society is composed of key talents in various specialized fields such as internal medicine, surgery, radiology, oncology, and pathology, playing a leading role not only domestically but also globally in the treatment of liver cancer. In particular, many efforts are being made to provide practical help by publishing various and useful materials that meet the eye level of patients and guardians. However, there are still a number of challenges to overcome in the treatment of liver cancer patients, so we want to develop and foster the society by preparing strategies to further revitalize clinical and basic intermediary research, and become a society where patients and their guardians work together," he said,
Meanwhile, the Korean Liver Cancer Society was founded in 1999 and celebrated its 25th anniversary this year. It is a multidisciplinary academic organization with experts from internal medicine, surgery, radiology, pathology, and radiation oncology for the purpose of improving liver cancer-related treatment and research, and currently has about 850 members.
Chairman Kim Kyung-sik majored in hepatopancreatic surgery and has conducted many clinical experiences and studies in the fields of liver cancer and biliary pancreatic cancer surgery.
Chairman Kim said "The Korean Liver Cancer Society is composed of key talents in various specialized fields such as internal medicine, surgery, radiology, oncology, and pathology, playing a leading role not only domestically but also globally in the treatment of liver cancer. In particular, many efforts are being made to provide practical help by publishing various and useful materials that meet the eye level of patients and guardians. However, there are still a number of challenges to overcome in the treatment of liver cancer patients, so we want to develop and foster the society by preparing strategies to further revitalize clinical and basic intermediary research, and become a society where patients and their guardians work together," he said,
Meanwhile, the Korean Liver Cancer Society was founded in 1999 and celebrated its 25th anniversary this year. It is a multidisciplinary academic organization with experts from internal medicine, surgery, radiology, pathology, and radiation oncology for the purpose of improving liver cancer-related treatment and research, and currently has about 850 members.
|
bellho@sportschosun.com
